Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01306058
Title Sorafenib and TRC105 in Hepatocellular Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)

hepatocellular carcinoma


Carotuximab + Sorafenib

Age Groups: adult
Covered Countries USA

No variant requirements are available.